133 related articles for article (PubMed ID: 31759728)
1. Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1.
Bhat SY; Jagruthi P; Srinivas A; Arifuddin M; Qureshi IA
Eur J Med Chem; 2020 Jan; 186():111860. PubMed ID: 31759728
[TBL] [Abstract][Full Text] [Related]
2. Development of quinoline-based hybrid as inhibitor of methionine aminopeptidase 1 from Leishmania donovani.
Bhat SY; Bhandari S; Thacker PS; Arifuddin M; Qureshi IA
Chem Biol Drug Des; 2021 Feb; 97(2):315-324. PubMed ID: 32816410
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of novel triazolyl quinoline derivatives as potential antileishmanial agents.
Upadhyay A; Kushwaha P; Gupta S; Dodda RP; Ramalingam K; Kant R; Goyal N; Sashidhara KV
Eur J Med Chem; 2018 Jun; 154():172-181. PubMed ID: 29793211
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationships and mechanistic studies of novel mitochondria-targeted, leishmanicidal derivatives of the 4-aminostyrylquinoline scaffold.
Staderini M; Piquero M; Abengózar MÁ; Nachér-Vázquez M; Romanelli G; López-Alvarado P; Rivas L; Bolognesi ML; Menéndez JC
Eur J Med Chem; 2019 Jun; 171():38-53. PubMed ID: 30904756
[TBL] [Abstract][Full Text] [Related]
5. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of 2-substituted quinolines as potential antileishmanial agents.
Gopinath VS; Pinjari J; Dere RT; Verma A; Vishwakarma P; Shivahare R; Moger M; Kumar Goud PS; Ramanathan V; Bose P; Rao MV; Gupta S; Puri SK; Launay D; Martin D
Eur J Med Chem; 2013 Nov; 69():527-36. PubMed ID: 24095747
[TBL] [Abstract][Full Text] [Related]
7. Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series.
Kieffer C; Cohen A; Verhaeghe P; Hutter S; Castera-Ducros C; Laget M; Remusat V; M'Rabet MK; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2015 Mar; 92():282-94. PubMed ID: 25559208
[TBL] [Abstract][Full Text] [Related]
8. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes.
Al-Qahtani A; Siddiqui YM; Bekhit AA; El-Sayed OA; Aboul-Enein HY; Al-Ahdalb MN
Arch Pharm (Weinheim); 2005 Oct; 338(10):484-7. PubMed ID: 16211660
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani.
Keurulainen L; Siiskonen A; Nasereddin A; Kopelyanskiy D; Sacerdoti-Sierra N; Leino TO; Tammela P; Yli-Kauhaluoma J; Jaffe CL; Kiuru P
Bioorg Med Chem Lett; 2015 May; 25(9):1933-7. PubMed ID: 25827525
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of perspicamide A and related diverse analogues: their bioevaluation as potent antileishmanial agents.
Pandey AK; Sharma R; Shivahare R; Arora A; Rastogi N; Gupta S; Chauhan PM
J Org Chem; 2013 Feb; 78(4):1534-46. PubMed ID: 23289499
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents.
Suryawanshi SN; Kumar S; Shivahare R; Pandey S; Tiwari A; Gupta S
Bioorg Med Chem Lett; 2013 Sep; 23(18):5235-8. PubMed ID: 23910597
[TBL] [Abstract][Full Text] [Related]
12. Antileishmanial ferrocenylquinoline derivatives: Synthesis and biological evaluation against Leishmania donovani.
Yousuf M; Mukherjee D; Dey S; Pal C; Adhikari S
Eur J Med Chem; 2016 Nov; 124():468-479. PubMed ID: 27598235
[TBL] [Abstract][Full Text] [Related]
13. Antileishmanial activity evaluation of bis-lawsone analogs and DNA topoisomerase-I inhibition studies.
Sharma G; Chowdhury S; Sinha S; Majumder HK; Kumar SV
J Enzyme Inhib Med Chem; 2014 Apr; 29(2):185-9. PubMed ID: 23534930
[TBL] [Abstract][Full Text] [Related]
14. The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors.
Sodji Q; Patil V; Jain S; Kornacki JR; Mrksich M; Tekwani BL; Oyelere AK
Bioorg Med Chem Lett; 2014 Oct; 24(20):4826-30. PubMed ID: 25240614
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-toxoplasmosis activity of 4-arylquinoline-2-carboxylate derivatives.
McNulty J; Vemula R; Bordón C; Yolken R; Jones-Brando L
Org Biomol Chem; 2014 Jan; 12(2):255-60. PubMed ID: 24276426
[TBL] [Abstract][Full Text] [Related]
16. Phase transfer catalyzed synthesis of bis-quinolines: antileishmanial activity in experimental visceral leishmaniasis and in vitro antibacterial evaluation.
Palit P; Paira P; Hazra A; Banerjee S; Gupta AD; Dastidar SG; Mondal NB
Eur J Med Chem; 2009 Feb; 44(2):845-53. PubMed ID: 18538452
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, stereoelectronic characterization and antiparasitic activity of new 1-benzenesulfonyl-2-methyl-1,2,3,4-tetrahydroquinolines.
Pagliero RJ; Lusvarghi S; Pierini AB; Brun R; Mazzieri MR
Bioorg Med Chem; 2010 Jan; 18(1):142-50. PubMed ID: 19942439
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of new furanyl and thiophenyl azoles as antileishmanial agents.
Marrapu VK; Mittal M; Shivahare R; Gupta S; Bhandari K
Eur J Med Chem; 2011 May; 46(5):1694-700. PubMed ID: 21385661
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of piperazinyl-β-carbolinederivatives as anti-leishmanial agents.
Ashok P; Chander S; Smith TK; Sankaranarayanan M
Eur J Med Chem; 2018 Apr; 150():559-566. PubMed ID: 29549840
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antileishmanial activity of novel 2,4,6-trisubstituted pyrimidines and 1,3,5-triazines.
Sunduru N; Nishi ; Palne S; Chauhan PM; Gupta S
Eur J Med Chem; 2009 Jun; 44(6):2473-81. PubMed ID: 19217698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]